BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28061855)

  • 1. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis.
    Mikami J; Kimura Y; Makari Y; Fujita J; Kishimoto T; Sawada G; Nakahira S; Nakata K; Tsujie M; Ohzato H
    World J Surg Oncol; 2017 Jan; 15(1):8. PubMed ID: 28061855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features and clinical outcomes of gastric cancer patients with bone metastasis.
    Nakamura K; Tomioku M; Nabeshima K; Yasuda S
    Tokai J Exp Clin Med; 2014 Dec; 39(4):193-8. PubMed ID: 25504207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.
    Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Tamura T; Yatabe T; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Gastric Cancer; 2019 Jul; 22(4):684-691. PubMed ID: 30417313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis.
    Park HS; Rha SY; Kim HS; Hyung WJ; Park JS; Chung HC; Noh SH; Jeung HC
    Oncology; 2011; 80(1-2):142-50. PubMed ID: 21677462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
    Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
    Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study.
    Xiaobin C; Zhaojun X; Tao L; Tianzeng D; Xuemei H; Fan Z; Chunyin H; Jianqiang H; Chen L
    J Immunol Res; 2022; 2022():3251051. PubMed ID: 35211630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
    Zhang MM; Lai M; Li YT; An Y; Yuan WZ
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinicopathological characteristics and prognostic analysis of bone metastasis in gastric cancer patients].
    Zhang H; Zhang RP; Li FX; Quan JC; Liu H; Deng JY; Wang XJ; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Apr; 16(4):354-7. PubMed ID: 23608798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of gastric cancer patients with bone marrow metastases.
    Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
    Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical analysis of bone metastasis of gastric cancer: incidence, clinicopathological features and survival.
    Wen L; Li YZ; Zhang J; Zhou C; Yang HN; Chen XZ; Xu LW; Kong SN; Wang XW; Zhang HM
    Future Oncol; 2019 Jul; 15(19):2241-2249. PubMed ID: 31215231
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathological features and prognosis of Borrmann type IV gastric cancer.
    Zhu YL; Yang L; Sui ZQ; Liu L; Du JF
    J BUON; 2016; 21(6):1471-1475. PubMed ID: 28039710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing survival in advanced gastric cancer.
    Tabuenca AD; Aitken DR; Ihde JK; Smith J; Garberoglio C
    Am Surg; 1993 Dec; 59(12):855-9. PubMed ID: 8256943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
    Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
    PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of prognostic factors in gastric cancer patients using additive hazards regression models.
    Maroufizadeh S; Hajizadeh E; Baghestani AR; Fatemi SR
    Asian Pac J Cancer Prev; 2011; 12(4):901-7. PubMed ID: 21790223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination.
    Chen S; Nie RC; OuYang LY; Li YF; Xiang J; Zhou ZW; Chen Y; Peng J
    World J Surg Oncol; 2017 Feb; 15(1):52. PubMed ID: 28228146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
    Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
    Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
    Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
    World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.